KMT2A and acute lymphoblastic leukemia: Our drug library screens resulted in the identification of the camptothecin-derived drug class of TOP1 inhibitors, which effectively inhibited MLL-rearranged ALL cell lines, as well as other ALL subtypes, with SN-38 as the most potent inhibitor of ALL cell viability.